Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Opinion: Sex inclusion in basic research drives discovery.
Boxed warning of HBV risk added to Rituxan, Arezerra
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide.
Oral Laquinimod for Multiple Sclerosis Treatment Significantly Reduced Disease Activity and Disability Progression While Providing Good Safety and Tolerability
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
Multifocal Tumefactive Demyelination Mimicking Intracranial Neoplasm.
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.
Berlex continues legal challenge to FDA over MS drug.
IL-17 and GM-CSF Expression Are Antagonistically Regulated by Human T Helper Cells.
Regulation of prefrontal cortex myelination by the microbiota.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Limit cycle oscillations in standing human posture.
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.

Pages